These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9270901)

  • 81. Acute effects of amperozide and paroxetine on social cohesion in male conspecifics.
    Rademacher DJ; Anderson AP; Steinpreis RE
    Brain Res Bull; 2002 Jun; 58(2):187-91. PubMed ID: 12127016
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Correlations between in vitro affinity of antipsychotics to various central neurotransmitter receptors and clinical incidence of their adverse drug reactions.
    Sekine Y; Rikihisa T; Ogata H; Echizen H; Arakawa Y
    Eur J Clin Pharmacol; 1999 Oct; 55(8):583-7. PubMed ID: 10541776
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A role for sigma binding in the antipsychotic profile of BMY 14802?
    Taylor DP; Eison MS; Moon SL; Schlemmer RF; Shukla UA; VanderMaelen CP; Yocca FD; Gallant DJ; Behling SH; Boissard CG
    NIDA Res Monogr; 1993; 133():125-57. PubMed ID: 8232511
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Profile of in vitro binding affinities of neuroleptics at different rat brain receptors: cluster analysis comparison with pharmacological and clinical profiles.
    Testa R; Abbiati G; Ceserani R; Restelli G; Vanasia A; Barone D; Gobbi M; Mennini T
    Pharm Res; 1989 Jul; 6(7):571-7. PubMed ID: 2571988
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Changes in the sensitivity of receptors for neurotransmitters and the actions of some psychotherapeutic drugs.
    Richelson E; El-Fakahany E
    Mayo Clin Proc; 1982 Sep; 57(9):576-82. PubMed ID: 6125630
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Substituted pyrazoles as novel selective ligands for the human dopamine D4 receptor.
    Bourrain S; Collins I; Neduvelil JG; Rowley M; Leeson PD; Patel S; Patel S; Emms F; Marwood R; Chapman KL; Fletcher AE; Showell GA
    Bioorg Med Chem; 1998 Oct; 6(10):1731-43. PubMed ID: 9839003
    [TBL] [Abstract][Full Text] [Related]  

  • 87. 1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain.
    Hamik A; Peroutka SJ
    Biol Psychiatry; 1989 Mar; 25(5):569-75. PubMed ID: 2537663
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Neuroleptic binding to human brain receptors: relation to clinical effects.
    Richelson E
    Ann N Y Acad Sci; 1988; 537():435-42. PubMed ID: 2904784
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system.
    Baker GB; Greenshaw AJ
    Cell Mol Neurobiol; 1989 Mar; 9(1):1-44. PubMed ID: 2565769
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Evidence that 5-HT(2) Antagonism Elicits a 5-HT(3)-Mediated Increase in Dopamine Transmission.
    Wu WH; Huang NK; Tseng CJ; Yin TH; Tung CS
    J Biomed Sci; 1995 Apr; 2(2):174-182. PubMed ID: 11725054
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Amino acid receptors and uptake systems in the mammalian central nervous system.
    Dingledine R; Boland LM; Chamberlin NL; Kawasaki K; Kleckner NW; Traynelis SF; Verdoorn TA
    Crit Rev Neurobiol; 1988; 4(1):1-96. PubMed ID: 2461808
    [TBL] [Abstract][Full Text] [Related]  

  • 92. 3H-Apomorphine receptors in various rat brain regions: a study of specific and nonspecific binding and the influence of chronic neuroleptic treatment.
    Leysen JE
    Adv Biochem Psychopharmacol; 1980; 24():123-32. PubMed ID: 6105770
    [No Abstract]   [Full Text] [Related]  

  • 93. Biotransformation of LASSBio-579 and pharmacological evaluation of p-hydroxylated metabolite a N-phenylpiperazine antipsychotic lead compound.
    Gomes TF; Pompeu TE; Rodrigues DA; Noël F; Menegatti R; Andrade CH; Sabino JR; Gil ES; Dalla Costa T; Betti AH; Antonio CB; Rates SM; Fraga CA; Barreiro EJ; de Oliveira V
    Eur J Med Chem; 2013 Apr; 62():214-21. PubMed ID: 23353740
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Receptor-ligand reaction in the central nervous system (principal problems and prospects for development)].
    Korneev AIa; Mukhin AG
    Vestn Akad Med Nauk SSSR; 1981; (5):56-9. PubMed ID: 6269319
    [No Abstract]   [Full Text] [Related]  

  • 95. Receptor profile of P88-8991 and P95-12113, metabolites of the novel antipsychotic iloperidone.
    Subramanian N; Kalkman HO
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):553-60. PubMed ID: 11999907
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Specific and potent interactions of carbamazepine with brain adenosine receptors.
    Marangos PJ; Post RM; Patel J; Zander K; Parma A; Weiss S
    Eur J Pharmacol; 1983 Sep; 93(3-4):175-82. PubMed ID: 6315450
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Receptor plasticity: biochemical correlates and pharmacological significance.
    Costa E
    Adv Biochem Psychopharmacol; 1980; 24():363-77. PubMed ID: 6105787
    [No Abstract]   [Full Text] [Related]  

  • 98. High frequency oral movements induced by long-term administration of amperozide but not FG5803 in rats.
    Liminga U; Andren PE; Ohlund LS; Gunne LM
    Psychopharmacology (Berl); 1996 Feb; 123(3):223-3O. PubMed ID: 8833415
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Pyrethroid-receptor interactions: stereospecific binding and effects on sodium channels in mouse brain preparations.
    Soderlund DM
    Neurotoxicology; 1985; 6(2):35-46. PubMed ID: 2410831
    [No Abstract]   [Full Text] [Related]  

  • 100. Evidence for drug actions on both pre- and postsynaptic catecholamine receptors in the CNS.
    Bunney BS; Aghajanian GK
    Psychopharmacol Bull; 1975 Oct; 11(4):8-10. PubMed ID: 724
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.